Conversion Disorder: "An Adverse Reaction" to Watch Out For

Dermatologic Clinics

Volumn 26, Issue 2, 2008, Pages 239-243

  Legaspi, Pearl Sherienne C ^a   Abad Venida, Ma Luisa ^a,b  

^a Jose R Reyes Memorial Medical Center   (Philippines)

^b Landcare Foundation of the Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; DIPHENHYDRAMINE; HALOPERIDOL; OFLOXACIN; RIFAMPICIN;

ADULT; CASE REPORT; CONVERSION DISORDER; EVENING DOSAGE; FEMALE; HUMAN; LEPROSY; NARCISSISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; WORLD HEALTH ORGANIZATION;

ADULT; ANTIDEPRESSIVE AGENTS; CONVERSION DISORDER; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; LEPROSTATIC AGENTS; LEPROSY; TREATMENT OUTCOME;

EID: 40849141133     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.11.008     Document Type: Review

References (21)

1. Akagi H., and House A. The epidemiology of hysterical conversion. In: Halligan P.W., Bass C., and Marshall J.C. (Eds). Contemporary approaches to the study of hysteria (2001), Oxford University Press, Oxford 73-87
2. Stone J., Smiyth R., Carson A., et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ 331 7523 (2005) 989-991
3. Matsuoka M., Kashiwabara Y., and Namisato M. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Int J Lepr Other Mycobact Dis 68 4 (2000) 452-455
4. Ebenezer G.J., Norman G., Joseph G.A., et al. Drug resistant-Mycobacterium leprae-results of mouse footpad studies from a laboratory in south India. Indian J Lepr 74 4 (2002) 301-312
5. Maeda S. Multi-drug resistant Mycobacterium leprae from patients with leprosy. Nihon Hansenbyo Gakkai Zasshi 73 3 (2004) 227-233
6. An introduction to Clinical Trials [Online]. 2005 Oct 17 [cited 2005 November]. Available at: http://www.clinicaltrials.gov/ct/info/.
7. Steffanson J.A., Messina J.A., and Meyerowitz S. Hysterical neurosis, conversion type: clinical and epidemiological consideration. Acta Psychiatr Scand 53 2 (1976) 119-138
8. Buffeli T.J., and Guze F.B. The simulation of neurologic disease. Psychiatr Clin North Am 15 2 (1992) 301-310
9. American Psychiatric Association. Somatoform disorders. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, DC 452-457
10. Hurwitz T.A. Somatization and conversion disorder. Can J Psychiatry 49 3 (2004) 172-178
11. Watson C.G., and Buranen C. The frequency and identification of false-positive conversion reactions. J Nerv Ment Dis 167 (1979) 243-247
12. Teasell R.W., and SHapiro A.P. Misdiagnosis of conversion disorders. Am J Phys Med Rehabil 81 3 (2002) 236-240
13. Hafeiz H.B. Hysterical conversion: a prognostic study. Br J Psychiatry 136 (1980) 548-551
14. Gatfield P.D., and Guze S.B. Prognosis and differential diagnosis of conversion reactions. Dis Nerv Syst 23 (1962) 623-631
15. Carter A.B. The prognosis of certain hysterical symptoms. BMJ 1 (1948) 1076-1078
16. Lempert T., and Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 237 1 (1990) 35-38
17. Ljungberg L. Hysteria: a clinical, prognostic and genetic study. Acta Psychiat Neurolog Scand Suppl 12 (1957) 37-48
18. Couprie W., Wijdicks E.F.M., Rooijmans H.G.M., et al. Outcome in conversion disorder: a follow-up study. J Neurol Neurosurg Psychiatry 58 (1995) 750-752
19. Mace C.J., and Trimble M.R. Ten-year prognosis of conversion disorder. Br J Psychiatry 169 (1996) 282-288
20. Binzer M., and Kullgren G. Motor conversion disorder. A prospective 2-5 year follow up study. Psychosomatics 39 (1998) 512-527
21. Speed J. Behavioral management of conversion disorder: retrospective study. Arch Phys Med Rehabil 77 2 (1996) 147-154